INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,570 | -7.6% | 6,438 | +20.3% | 0.00% | -33.3% |
| Q2 2023 | $220,355 | +6.9% | 5,352 | -3.3% | 0.00% | 0.0% |
| Q1 2023 | $206,216 | -94.1% | 5,533 | -52.4% | 0.00% | -90.0% |
| Q4 2022 | $3,520,570 | +438.0% | 11,628 | -0.7% | 0.03% | +400.0% |
| Q3 2022 | $654,422 | +112.1% | 11,712 | +96.5% | 0.01% | -14.3% |
| Q2 2022 | $308,490 | +13.0% | 5,960 | +58.9% | 0.01% | +16.7% |
| Q1 2022 | $273,000 | -38.7% | 3,751 | -0.5% | 0.01% | -45.5% |
| Q4 2021 | $445,000 | -12.6% | 3,769 | -0.8% | 0.01% | -26.7% |
| Q3 2021 | $509,000 | -17.0% | 3,800 | +0.4% | 0.02% | -16.7% |
| Q2 2021 | $613,000 | +49.5% | 3,783 | -25.9% | 0.02% | +28.6% |
| Q1 2021 | $410,000 | +314.1% | 5,105 | +181.4% | 0.01% | +250.0% |
| Q4 2020 | $99,000 | +175.0% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $36,000 | -5.3% | 1,814 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $38,000 | +72.7% | 1,814 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $22,000 | -91.7% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $266,000 | +1008.3% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $24,000 | -20.0% | 1,814 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $30,000 | -3.2% | 1,814 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $31,000 | +24.0% | 1,814 | 0.0% | 0.00% | -42.9% |
| Q4 2018 | $25,000 | -51.9% | 1,814 | 0.0% | 0.01% | -56.2% |
| Q3 2018 | $52,000 | +36.8% | 1,814 | 0.0% | 0.02% | -23.8% |
| Q1 2018 | $38,000 | +8.6% | 1,814 | 0.0% | 0.02% | +10.5% |
| Q4 2017 | $35,000 | +20.7% | 1,814 | 0.0% | 0.02% | +58.3% |
| Q2 2017 | $29,000 | +11.5% | 1,814 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $26,000 | -16.1% | 1,814 | 0.0% | 0.01% | -56.2% |
| Q3 2016 | $31,000 | -20.5% | 1,814 | 0.0% | 0.03% | -13.5% |
| Q2 2016 | $39,000 | – | 1,814 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |